Market News How it works Learn FAQ
| GPUS 0.1689 34.05% | SHFS 0.1324 -61.39% | XXII 0.1977 -8.34% | NVD 4.19 0.96% | LUCD 0.411 25.42% | SPCX 147.49 1.89% | T 20.93 -7.96% | SOXL 83.56 1.77% | NU 15.16 2.92% | NOK 8.14 3.30% | EWZ 42.59 1.77% | NVDA 210.96 -0.59% | RIME 0.106 -12.90% | INTC 86.96 1.72% | TSLG 4.87 -1.62% | AAL 12.11 -3.89% | BBD 4.07 3.04% | STLA 4.06 -4.81% | SOXS 52.46 -1.85% | RWM 14.55 0.34% | HYG 77.05 -0.06% | MYND 0.24 47.42% | RBNE 0.19 -2.56% | YFOR 0.2236 -1.58% | BITO 10.83 -0.28% | SPDN 8.54 0.47% | TQQQ 66.29 -0.20% | TSLL 9.76 -1.21% | VZ 44.66 -1.19% | SPTI 27.63 -0.11% | YMAT 2.05 6.77% | CRWV 54.235 -2.46% | INFY 12.35 -6.58% | RIG 6.41 5.43% | F 11.6 -2.85% | GRAB 2.79 -2.11% | AIOK 12.02 182.82% | SQQQ 39.68 0.20% | ONDS 6.2 2.99% | LABT 0.31 -36.67% | AAPL 347.725 -0.14% | CDE 13.45 -3.10% | PCG 12.63 -2.70% | IREN 24.905 -2.37% | SOFI 14.615 -1.05% | XLE 69.33 2.60% | NFLX 65.85 -1.79% | QID 14.55 0.14% | CLRO 3.25 69.27% | WULF 11.32 0.00%
PRPerrigo Company plc logo

Perrigo Company plc (PRGO)

New York Stock Exchange · Currency in USD
$15.96 ▼ -0.41 (-2.50%)
At close: Oct 23, 4:00 PM ET. Market closed.

Summary

Previous Close
$16.37
Open
$16.22
Day's Range
$15.88 – $16.31
52 Week Range
$9.23 – $22.01
Volume
1,555,734
Avg. Volume
3,098,021
Market Cap
$2.21B
Beta (5Y Monthly)
0.54
PE Ratio (TTM)
--
EPS (TTM)
-$12.47
Earnings Date
Nov 4, 2026
Forward Dividend & Yield
$1.16 (7.27%)
Ex-Dividend Date
Aug 28, 2026
1y Target Est
$36.20

Profile: Perrigo Company plc

Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Full-time employees
8,100
CEO
Albert A. Manzone

Perrigo Company plc provides over-the-counter health and wellness solutions in the United States, Europe, and internationally. The company operates through Consumer Self-Care Americas and Consumer Self-Care International segments. It offers upper respiratory products, including cough suppressants, expectorants, and sinus and allergy relief; nutrition products consisting of infant formulas and oral electrolyte beverages; digestive health products, including antacids, anti-diarrheal, and anti-heartburn; pain and sleep-aids products comprising pain relievers and fever reducers; and oral care products, which include toothbrushes, toothbrush replacement heads, floss, flossers, whitening products, and toothbrush covers.

Earnings

Next report: Wed, Nov 4, 2026
EPS estimate $0.51 · Revenue est. $987.20M
DateEst.Actual
Aug 5, 2026$0.39$0.50Beat
May 6, 2026$0.39$0.43Beat
Feb 26, 2026$0.80$0.77Miss
Nov 5, 2025$0.75$0.80Beat
Aug 6, 2025$0.59$0.57Miss
May 7, 2025$0.56$0.60Beat

Analyst view

Consensus price target
$36.20 ▲ +126.8%
Range $20.00 – $54.00
Rating: Hold
Buy 39% · Hold 58% · Sell 3%

Get free alerts on PRGO and big market moves

Free special alerts by text & email on new investment opportunities, buyouts and the stocks moving most, in plain English.
Get free stock alerts →
Data: Financial Modeling Prep. For information only, not investment advice.